Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

753958

	registered interest
	date	19/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radioisotopes: Imports
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit.
	tabling member printed	Lord Mendelsohn
	uin	HL1104
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The Government is fully aware of the importance of molybdenum-99 and the reliance on this medical radioisotope for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in everyone’s interest to not disrupt the timely access of treatment to patients and to ensure that cross-border trade with the European Union and Euratom is as frictionless as possible.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:38:56 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4286 label Biography information for Lord Mendelsohn

751979

	registered interest
	date	13/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Financial Services: Greater London
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many individuals infected with blood contaminated by hepatitis C or HIV in the 1970s and 1980s remain alive.
	tabling member printed	Lord Black of Brentwood
	uin	HL814
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Department does not hold this information.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:09:01 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4171 label Biography information for Lord Black of Brentwood

755111

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many patients from BME backgrounds spent a period of their care in locked wards in England during each of the last three years for which figures are available.
	tabling member printed	Lord Boateng
	uin	HL1119
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng

752468

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Parkinson's Disease: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how much the NHS pays for a one year supply of Apomorphine for a patient with Parkinson's Disease; how much they estimate it costs to manufacture a year's supply of that drug; what assessment they have made of the difficulties of manufacturing Apomorphine to clinical standards; and whether they intend to take any steps to reduce the cost of that drug to the NHS.
	tabling member printed	Lord Lucas
	uin	HL914
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The drug cost to the National Health Service for a one year supply of Apomorphine for a patient with Parkinson's Disease is estimated to be in the region of £5,300 and £9,000, based on the usual daily dose of 3 – 30mg. However, the maximum daily is 100mg, so the annual cost for some patient’s treatment may be higher.</p><p>We have no estimate of the cost of manufacture. We are not aware of any particular issues relating to the manufacture of this drug. Pharmaceutical companies participate in either the voluntary pharmaceutical price regulation scheme (PPRS) or the statutory medicines price regulation scheme, both of which regulate the cost of medicines to the NHS. Products covered by the statutory scheme are subject to a 15% cut to their list price. Companies in the PPRS pay a percentage of sales to the Government when growth in NHS spending on medicines exceeds an agreed level. NHS purchasers may also negotiate discounts with pharmaceutical companies in addition to national price regulation.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:12:09 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1879 label Biography information for Lord Lucas

750534

	registered interest
	date	11/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Democratic Republic of Congo: Mining
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what assessment they have made of the level of suicide among teenagers in the UK.
	tabling member printed	Lord Eames
	uin	HL666
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Office for National Statistics publishes annual statistics on suicide registrations for the United Kingdom, including age-specific suicide rates by five-year age groups. A table attached provides statistics for suicides in people aged 10-14 and 15-19 in the UK between 1981 and 2015, the latest data available, is attached due to the size of the data.</p><p> </p><p>The Department leads delivery of the Cross-Government Suicide Prevention Strategy for England. Suicide prevention is a devolved matter in other UK countries.</p><p> </p><p>The National Confidential Inquiry into Suicide and Homicide by People with Mental Illness, which is commissioned by NHS England and supported by the Department, published a thematic review in 2016, Suicide by Children and Young People in England. The report identified ten common themes relating to suicides by people under 20 years of age:</p><p> </p><p>- family factors such as mental illness;</p><p>- abuse and neglect;</p><p>- bereavement and experience of suicide;</p><p>- bullying;</p><p>- suicide-related internet use;</p><p>- academic pressures, especially related to exams;</p><p>- social isolation or withdrawal;</p><p>- physical health conditions that may have social impact;</p><p>- alcohol and illicit drugs; and</p><p>- mental ill health, self-harm and suicidal ideas.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:11:50 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name HL666 formatted table.docx title Suicides in UK 1981-2015 10-19 year olds
	tabling member	2793 label Biography information for Lord Eames

755112

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what conclusions they have drawn from the Care Quality Commission review The state of care in mental health services 2014 to 2017, published on 20 July, as to the numbers and experience of BME patients in locked wards across England.
	tabling member printed	Lord Boateng
	uin	HL1120
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1119 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng

753910

	registered interest
	date	19/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Mortality Rates
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what is their assessment of the findings by Integrating the Healthcare Enterprise in its report, Comparator report on patient access to cancer medicines in Europe Revisited, that UK five-year survival outcomes for cancer lag behind the European average for nine out of ten cancers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL1056
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Cancer survival rates are at a record high and around 7,000 more people are surviving cancer after successful treatment on the National Health Service compared to three years ago. However, there is more that we can do. NHS England is leading the implementation of the recommendations of the independent Cancer Taskforce to save a further 30,000 lives by 2020.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:27:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

755129

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Blood: Contamination
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether the findings of the 2009 independent report by Lord Archer of Sandwell on NHS supplied contaminated blood and blood products will be taken into account by the contaminated blood inquiry announced on 11 July.
	tabling member printed	Baroness Gould of Potternewton
	uin	HL1137
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The focus of the inquiry will be on establishing the truth of what happened.</p><p> </p><p>Over the summer, the Government is consulting with those affected and key stakeholder groups to discuss the scope of the inquiry.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:25:47 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3573 label Biography information for Baroness Gould of Potternewton

751130

	registered interest
	date	12/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Religious Hatred
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether they intend to prepare a strategy for prisoners with dementia; and if so, when it will be published.
	tabling member printed	Lord Bradley
	uin	HL727
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>There are currently no plans to develop a specific strategy for prisoners with dementia.</p><p> </p><p>The Challenge on Dementia 2020 sets out the Government’s ambition to follow up timely diagnosis with greater access to support for people with dementia, increase public awareness and create more dementia friendly public and private organisations and communities across all settings.</p><p> </p><p>Health services in prisons are commissioned by NHS England and implementing specialist dementia services across appropriate prison settings is one of its commissioning intentions for 2017-18.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:10:13 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	452 label Biography information for Lord Bradley

755110

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government, what data are collected regarding the number of BME patients in locked wards in England; and what plans they have to impose new requirements for the collection of such data.
	tabling member printed	Lord Boateng
	uin	HL1118
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1119 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng